<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Bronchodilators</id>
	<title>Bronchodilators - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://mfrdinfo.com/ems1/index.php?action=history&amp;feed=atom&amp;title=Bronchodilators"/>
	<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Bronchodilators&amp;action=history"/>
	<updated>2026-08-17T10:27:53Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.32.0</generator>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Bronchodilators&amp;diff=260&amp;oldid=prev</id>
		<title>Mfrdmanager: Protected &quot;Bronchodilators&quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Bronchodilators&amp;diff=260&amp;oldid=prev"/>
		<updated>2018-02-10T17:25:29Z</updated>

		<summary type="html">&lt;p&gt;Protected &amp;quot;&lt;a href=&quot;/ems1/index.php?title=Bronchodilators&quot; title=&quot;Bronchodilators&quot;&gt;Bronchodilators&lt;/a&gt;&amp;quot; ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;1&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 17:25, 10 February 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-notice&quot; lang=&quot;en&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(No difference)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
	<entry>
		<id>http://mfrdinfo.com/ems1/index.php?title=Bronchodilators&amp;diff=259&amp;oldid=prev</id>
		<title>Mfrdmanager: Created page with &quot;==Section 8 - MEDICATION GUIDELINES== === 8.11 BRONCHODILATORS===  ==== Albuterol (PROVENTIL, VENTOLIN) / Bronchodilator==== '''DESCRIPTION''' * It is a synthetic sympathomime...&quot;</title>
		<link rel="alternate" type="text/html" href="http://mfrdinfo.com/ems1/index.php?title=Bronchodilators&amp;diff=259&amp;oldid=prev"/>
		<updated>2018-02-10T17:25:22Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 8 - MEDICATION GUIDELINES== === 8.11 BRONCHODILATORS===  ==== Albuterol (PROVENTIL, VENTOLIN) / Bronchodilator==== &amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039; * It is a synthetic sympathomime...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 8 - MEDICATION GUIDELINES==&lt;br /&gt;
=== 8.11 BRONCHODILATORS===&lt;br /&gt;
&lt;br /&gt;
==== Albuterol (PROVENTIL, VENTOLIN) / Bronchodilator====&lt;br /&gt;
'''DESCRIPTION'''&lt;br /&gt;
* It is a synthetic sympathomimetic that causes bronchodilation with less cardiac effect than Epinephrine. The duration of effect is about four hours.&lt;br /&gt;
'''INDICATIONS'''&lt;br /&gt;
* [[Acute Asthma or COPD with Wheezing|Acute Asthma]], [[Acute Asthma or COPD with Wheezing|COPD with wheezing]].&lt;br /&gt;
'''CONTRAINDICATIONS'''&lt;br /&gt;
* Hypersensitivity to the medication.&lt;br /&gt;
'''PRECAUTIONS'''&lt;br /&gt;
* The patient may experience palpitations, anxiety, nausea, and/or dizziness. Vital signs must be monitored; use caution with cardiac or hypertensive patients.&lt;br /&gt;
'''DOSAGE'''&lt;br /&gt;
* Adult: 2.5 mg updraft AND refer to appropriate PRACTICE PARAMETER for specific dosage.&lt;br /&gt;
* Pediatrics: Refer to Handtevy System&lt;br /&gt;
** Less than 12 months: 1.25 mg updraft&lt;br /&gt;
** 1 year and older: 2.5 mg&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Ipatropium Bromide (ATROVENT) / Bronchodilator====&lt;br /&gt;
'''DESCRIPTION'''&lt;br /&gt;
* Inhibits interaction of acetylcholine at receptor sites on the bronchial smooth muscle, resulting in decreased cGMP and bronchodilation.&lt;br /&gt;
'''INDICATIONS'''&lt;br /&gt;
* For the treatment of bronchospasm associated with [[Acute Asthma or COPD with Wheezing|chronic pulmonary disease, including asthma, bronchitis, and emphysema]].&lt;br /&gt;
'''CONTRAINDICATIONS'''&lt;br /&gt;
* Hypersensitivity to Ipratropium Bromide, or to atropine and its derivatives. Not for use in CHF or cardiac asthma.&lt;br /&gt;
'''PRECAUTIONS'''&lt;br /&gt;
* Use with caution in patients with narrow angle glaucoma, prostatic hypertrophy or bladder neck obstruction.&lt;br /&gt;
'''DOSAGE'''&lt;br /&gt;
* 0.5 mg updraft AND refer to appropriate PRACTICE PARAMETER for specific dosage.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Levalbuterol (XOPENEX) / Beta2-Adrenergic Receptor Agonist / Bronchodilator====&lt;br /&gt;
'''DESCRIPTION'''&lt;br /&gt;
* Xopenex (levalbuterol HCl) Inhalation Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of levalbuterol, the (R)-enantiomer of the drug substance racemic albuterol. Levalbuterol HCl is a relatively selective beta2-adrenergic receptor agonist&lt;br /&gt;
'''INDICATIONS'''&lt;br /&gt;
* For the treatment of bronchospasm associated with [[Acute Asthma or COPD with Wheezing|asthma or COPD with wheezing]].&lt;br /&gt;
'''CONTRAINDICATIONS'''&lt;br /&gt;
* Xopenex (levalbuterol HCl) Inhalation Solution is contraindicated in patients with a history of hypersensitivity to levalbuterol HCl or racemic albuterol.&lt;br /&gt;
'''PRECAUTIONS'''&lt;br /&gt;
* Levalbuterol HCl, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines.&lt;br /&gt;
* Use with Beta-blockers, diuretics, Digoxin, antihistamines or tricyclic antidepressants may cause adverse cardiac effects.&lt;br /&gt;
'''DOSAGE'''&lt;br /&gt;
* Adults: 1.25 mg nebulized via updraft&lt;br /&gt;
* Pediatrics: refer to Handtevy System&lt;br /&gt;
** Less than 6 years of age: 0.31 mg nebulized via updraft added to 2.5 ml of normal saline&lt;br /&gt;
** 6 years and older: 0.63 mg nebulized via updraft added to 2.5 ml of normal saline&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
====Vaponefrine (RACEMIC EPINEPHRINE) / Bronchodilator, Adrenergic====&lt;br /&gt;
'''DESCRIPTION'''&lt;br /&gt;
* Slightly different chemically from epinephrine. Stimulates both alpha and beta adrenergic receptors with a slight preference for the beta2 receptors in the lungs. This results in bronchodilation and a decrease in mucus secretion. It also helps in relieving the subglottic edema associated with croup when administered by inhalation.&lt;br /&gt;
'''INDICATIONS'''&lt;br /&gt;
* For the treatment of bronchospasm associated with [[Infectious Upper Airway Obstruction - Croup or Epiglottitis|croup]].&lt;br /&gt;
'''CONTRAINDICATIONS'''&lt;br /&gt;
* Epiglottitis, severe tachyarrhythmias.&lt;br /&gt;
'''PRECAUTIONS'''&lt;br /&gt;
* Use with antihistamines or tricyclic antidepressants may cause adverse cardiac effects.&lt;br /&gt;
'''DOSAGE'''&lt;br /&gt;
* 0.5 mg nebulized via updraft added to 3 ml of normal saline AND refer to appropriate PRACTICE PARAMETER for specific dosage.&lt;br /&gt;
&lt;br /&gt;
[[Category:Medication Guidelines|0811]]&lt;/div&gt;</summary>
		<author><name>Mfrdmanager</name></author>
		
	</entry>
</feed>